🚀 VC round data is live in beta, check it out!
Swedencare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Swedencare and similar public comparables like Invivyd, 2seventy bio, Regenxbio, Larimar Therapeutics and more.
Swedencare Overview
About Swedencare
Swedencare AB specializes in pet healthcare. It develops, manufactures partly in its factories, markets, and sells products in the fast-growing market of healthcare products for cats, dogs, and horses. The group has an extensive portfolio of brands and products in various therapy areas, including Animal Pharmaceuticals, Nutravet, NutriScience, Pet MD, Stratford, VetWELL, ProDen PlaqueOff, Rx Vitamins, Riley’s, NaturVet, Pet Organics, Overby Farm, Vet Classics, and Innovet’s brands. Its products are sold to veterinarians, pet stores, and online through a distribution network comprising various subsidiaries and an international network of retailers. The group's operating segments include North America, which generates maximum revenue, Europe, and Production.
Founded
2010
HQ
Employees
579
Website
Sectors
Financials (LTM)
EV
$679M
Swedencare Financials
Swedencare reported last 12-month revenue of $307M and EBITDA of $60M.
In the same LTM period, Swedencare generated $175M in gross profit, $60M in EBITDA, and $10M in net income.
Revenue (LTM)
Swedencare P&L
In the most recent fiscal year, Swedencare reported revenue of $303M and EBITDA of $57M.
Swedencare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $307M | XXX | $303M | XXX | XXX | XXX |
| Gross Profit | $175M | XXX | $164M | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 54% | XXX | XXX | XXX |
| EBITDA | $60M | XXX | $57M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $10M | XXX | $6M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $148M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Swedencare Stock Performance
Swedencare has current market cap of $494M, and enterprise value of $679M.
Market Cap Evolution
Swedencare's stock price is $3.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $679M | $494M | 2.6% | XXX | XXX | XXX | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSwedencare Valuation Multiples
Swedencare trades at 2.2x EV/Revenue multiple, and 11.3x EV/EBITDA.
EV / Revenue (LTM)
Swedencare Financial Valuation Multiples
As of April 18, 2026, Swedencare has market cap of $494M and EV of $679M.
Equity research analysts estimate Swedencare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Swedencare has a P/E ratio of 48.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $494M | XXX | $494M | XXX | XXX | XXX |
| EV (current) | $679M | XXX | $679M | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 11.3x | XXX | 11.9x | XXX | XXX | XXX |
| EV/EBIT | 21.6x | XXX | 24.9x | XXX | XXX | XXX |
| EV/Gross Profit | 3.9x | XXX | 4.1x | XXX | XXX | XXX |
| P/E | 48.0x | XXX | 79.1x | XXX | XXX | XXX |
| EV/FCF | (143.6x) | XXX | 22.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Swedencare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Swedencare Margins & Growth Rates
Swedencare's revenue in the last 12 month grew by 6%.
Swedencare's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.3M for the same period.
Swedencare's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Swedencare's rule of X is 43% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Swedencare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 17% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 30% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Swedencare Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Swedencare | XXX | XXX | XXX | XXX | XXX | XXX |
| Invivyd | XXX | XXX | XXX | XXX | XXX | XXX |
| 2seventy bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Regenxbio | XXX | XXX | XXX | XXX | XXX | XXX |
| Larimar Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Medigen Vaccine Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Swedencare M&A Activity
Swedencare acquired XXX companies to date.
Last acquisition by Swedencare was on XXXXXXXX, XXXXX. Swedencare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Swedencare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSwedencare Investment Activity
Swedencare invested in XXX companies to date.
Swedencare made its latest investment on XXXXXXXX, XXXXX. Swedencare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Swedencare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Swedencare
| When was Swedencare founded? | Swedencare was founded in 2010. |
| Where is Swedencare headquartered? | Swedencare is headquartered in Sweden. |
| How many employees does Swedencare have? | As of today, Swedencare has over 579 employees. |
| Who is the CEO of Swedencare? | Swedencare's CEO is Hakan Lagerberg. |
| Is Swedencare publicly listed? | Yes, Swedencare is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Swedencare? | Swedencare trades under SECARE ticker. |
| When did Swedencare go public? | Swedencare went public in 2016. |
| Who are competitors of Swedencare? | Swedencare main competitors are Invivyd, 2seventy bio, Regenxbio, Larimar Therapeutics. |
| What is the current market cap of Swedencare? | Swedencare's current market cap is $494M. |
| What is the current revenue of Swedencare? | Swedencare's last 12 months revenue is $307M. |
| What is the current revenue growth of Swedencare? | Swedencare revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Swedencare? | Current revenue multiple of Swedencare is 2.2x. |
| Is Swedencare profitable? | Yes, Swedencare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Swedencare? | Swedencare's last 12 months EBITDA is $60M. |
| What is Swedencare's EBITDA margin? | Swedencare's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Swedencare? | Current EBITDA multiple of Swedencare is 11.3x. |
| What is the current FCF of Swedencare? | Swedencare's last 12 months FCF is ($5M). |
| What is Swedencare's FCF margin? | Swedencare's last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Swedencare? | Current FCF multiple of Swedencare is (143.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.